U
CVR Medical Corp.
CVMH.V
TSX
E
Sell
5/1/2023Downgrade
CVR Medical Corp. (CVMH.V) was downgraded to E- from D- on 5/1/2023 due to a decline in the volatility index.
CVR Medical Corp. (CVMH.V) was downgraded to E- from D- on 5/1/2023 due to a decline in the volatility index.
D
Sell
3/6/2023Upgraded
CVR Medical Corp. (CVMH.V) was upgraded to D- from E+ on 3/6/2023 due to an increase in the volatility index and total return index.
CVR Medical Corp. (CVMH.V) was upgraded to D- from E+ on 3/6/2023 due to an increase in the volatility index and total return index.
E
Sell
2/17/2023Downgrade
CVR Medical Corp. (CVMH.V) was downgraded to E+ from D- on 2/17/2023 due to a decline in the volatility index.
CVR Medical Corp. (CVMH.V) was downgraded to E+ from D- on 2/17/2023 due to a decline in the volatility index.
D
Sell
1/30/2023Upgraded
CVR Medical Corp. (CVMH.V) was upgraded to D- from E+ on 1/30/2023 due to an increase in the volatility index and total return index.
CVR Medical Corp. (CVMH.V) was upgraded to D- from E+ on 1/30/2023 due to an increase in the volatility index and total return index.
E
Sell
12/19/2022Downgrade
CVR Medical Corp. (CVMH.V) was downgraded to E+ from D- on 12/19/2022 due to a decline in the total return index and volatility index.
CVR Medical Corp. (CVMH.V) was downgraded to E+ from D- on 12/19/2022 due to a decline in the total return index and volatility index.
D
Sell
11/23/2022Upgraded
CVR Medical Corp. (CVMH.V) was upgraded to D- from E+ on 11/23/2022 due to an increase in the total return index and volatility index.
CVR Medical Corp. (CVMH.V) was upgraded to D- from E+ on 11/23/2022 due to an increase in the total return index and volatility index.
E
Sell
11/3/2022Downgrade
CVR Medical Corp. (CVMH.V) was downgraded to E+ from D- on 11/3/2022 due to a decline in the volatility index.
CVR Medical Corp. (CVMH.V) was downgraded to E+ from D- on 11/3/2022 due to a decline in the volatility index.
D
Sell
10/19/2022Upgraded
CVR Medical Corp. (CVMH.V) was upgraded to D- from E+ on 10/19/2022 due to an increase in the total return index and volatility index.
CVR Medical Corp. (CVMH.V) was upgraded to D- from E+ on 10/19/2022 due to an increase in the total return index and volatility index.
E
Sell
7/21/2022Downgrade
CVR Medical Corp. (CVM.V) was downgraded to E+ from D- on 7/21/2022 due to a noticeable decline in the growth index. Operating cash flow declined 2.34% from -$51.3 to -$52.5.
CVR Medical Corp. (CVM.V) was downgraded to E+ from D- on 7/21/2022 due to a noticeable decline in the growth index. Operating cash flow declined 2.34% from -$51.3 to -$52.5.
D
Sell
7/15/2022Downgrade
CVR Medical Corp. (CVM.V) was downgraded to D- from D on 7/15/2022 due to a significant decline in the valuation index, efficiency index and solvency index. Net income declined 469.12% from -$243.5 to -$1.39M, total capital declined 43.11% from -$2.74M to -$3.93M, and debt to equity increased from -0.15 to -0.12.
CVR Medical Corp. (CVM.V) was downgraded to D- from D on 7/15/2022 due to a significant decline in the valuation index, efficiency index and solvency index. Net income declined 469.12% from -$243.5 to -$1.39M, total capital declined 43.11% from -$2.74M to -$3.93M, and debt to equity increased from -0.15 to -0.12.
D
Sell
4/29/2022Downgrade
CVR Medical Corp. (CVM.V) was downgraded to D from D+ on 4/29/2022 due to a decline in the total return index and volatility index.
CVR Medical Corp. (CVM.V) was downgraded to D from D+ on 4/29/2022 due to a decline in the total return index and volatility index.
D
Sell
3/21/2022Upgraded
CVR Medical Corp. (CVM.V) was upgraded to D+ from D on 3/21/2022 due to an increase in the volatility index, valuation index and total return index.
CVR Medical Corp. (CVM.V) was upgraded to D+ from D on 3/21/2022 due to an increase in the volatility index, valuation index and total return index.
D
Sell
3/4/2022Downgrade
CVR Medical Corp. (CVM.V) was downgraded to D from D+ on 3/4/2022 due to a decline in the volatility index.
CVR Medical Corp. (CVM.V) was downgraded to D from D+ on 3/4/2022 due to a decline in the volatility index.
D
Sell
2/16/2022Upgraded
CVR Medical Corp. (CVM.V) was upgraded to D+ from D on 2/16/2022 due to an increase in the volatility index.
CVR Medical Corp. (CVM.V) was upgraded to D+ from D on 2/16/2022 due to an increase in the volatility index.
D
Sell
12/1/2021Downgrade
CVR Medical Corp. (CVM.V) was downgraded to D from C- on 12/1/2021 due to a substantial decline in the growth index and volatility index. Operating cash flow declined 298.24% from $28.4 to -$56.3, earnings per share declined from $0.0015 to -$0.0024, and EBIT declined 231.55% from $130.6 to -$171.8.
CVR Medical Corp. (CVM.V) was downgraded to D from C- on 12/1/2021 due to a substantial decline in the growth index and volatility index. Operating cash flow declined 298.24% from $28.4 to -$56.3, earnings per share declined from $0.0015 to -$0.0024, and EBIT declined 231.55% from $130.6 to -$171.8.
C
Hold
11/23/2021Upgraded
CVR Medical Corp. (CVM.V) was upgraded to C- from D+ on 11/23/2021 due to a noticeable increase in the total return index, valuation index and volatility index.
CVR Medical Corp. (CVM.V) was upgraded to C- from D+ on 11/23/2021 due to a noticeable increase in the total return index, valuation index and volatility index.
D
Sell
10/1/2021Upgraded
CVR Medical Corp. (CVM.V) was upgraded to D+ from D on 10/1/2021 due to an increase in the total return index.
CVR Medical Corp. (CVM.V) was upgraded to D+ from D on 10/1/2021 due to an increase in the total return index.
D
Sell
9/2/2021Upgraded
CVR Medical Corp. (CVM.V) was upgraded to D from E+ on 9/2/2021 due to a significant increase in the valuation index, efficiency index and growth index. Operating cash flow increased 408.7% from -$9.2 to $28.4, earnings per share increased from -$0.0033 to $0.0015, and net income increased 143.96% from -$336 to $147.7.
CVR Medical Corp. (CVM.V) was upgraded to D from E+ on 9/2/2021 due to a significant increase in the valuation index, efficiency index and growth index. Operating cash flow increased 408.7% from -$9.2 to $28.4, earnings per share increased from -$0.0033 to $0.0015, and net income increased 143.96% from -$336 to $147.7.
E
Sell
6/11/2021Downgrade
CVR Medical Corp. (CVM.V) was downgraded to E+ from D- on 6/11/2021 due to a decline in the volatility index and total return index.
CVR Medical Corp. (CVM.V) was downgraded to E+ from D- on 6/11/2021 due to a decline in the volatility index and total return index.
D
Sell
6/2/2021Downgrade
CVR Medical Corp. (CVM.V) was downgraded to D- from D on 6/2/2021 due to a substantial decline in the growth index and valuation index. EBIT declined 165.72% from $486.6 to -$319.8, earnings per share declined from $0.0081 to -$0.0033, and operating cash flow declined 102.62% from $351.2 to -$9.2.
CVR Medical Corp. (CVM.V) was downgraded to D- from D on 6/2/2021 due to a substantial decline in the growth index and valuation index. EBIT declined 165.72% from $486.6 to -$319.8, earnings per share declined from $0.0081 to -$0.0033, and operating cash flow declined 102.62% from $351.2 to -$9.2.
D
Sell
12/22/2020Upgraded
CVR Medical Corp. (CVM.V) was upgraded to D from D- on 12/22/2020 due to an increase in the volatility index.
CVR Medical Corp. (CVM.V) was upgraded to D from D- on 12/22/2020 due to an increase in the volatility index.
D
Sell
8/21/2020Upgraded
CVR Medical Corp. (CVM.V) was upgraded to D- from E+ on 8/21/2020 due to a substantial increase in the growth index and volatility index. EBIT increased 77.08% from -$1.07M to -$244.2, and earnings per share increased from -$0.012 to -$0.0035.
CVR Medical Corp. (CVM.V) was upgraded to D- from E+ on 8/21/2020 due to a substantial increase in the growth index and volatility index. EBIT increased 77.08% from -$1.07M to -$244.2, and earnings per share increased from -$0.012 to -$0.0035.
E
Sell
8/12/2020Downgrade
CVR Medical Corp. (CVM.V) was downgraded to E+ from D- on 8/12/2020 due to a large decline in the growth index, total return index and volatility index. EBIT declined 351.48% from -$236 to -$1.07M, earnings per share declined from -$0.0027 to -$0.012, and operating cash flow declined 161.03% from -$19.5 to -$50.9.
CVR Medical Corp. (CVM.V) was downgraded to E+ from D- on 8/12/2020 due to a large decline in the growth index, total return index and volatility index. EBIT declined 351.48% from -$236 to -$1.07M, earnings per share declined from -$0.0027 to -$0.012, and operating cash flow declined 161.03% from -$19.5 to -$50.9.
D
Sell
6/11/2020Downgrade
CVR Medical Corp. (CVM.V) was downgraded to D- from D on 6/11/2020 due to a significant decline in the efficiency index, solvency index and volatility index.
CVR Medical Corp. (CVM.V) was downgraded to D- from D on 6/11/2020 due to a significant decline in the efficiency index, solvency index and volatility index.
D
Sell
2/12/2020Downgrade
CVR Medical Corp. (CVM.V) was downgraded to D from D+ on 2/12/2020 due to a noticeable decline in the total return index, growth index and volatility index.
CVR Medical Corp. (CVM.V) was downgraded to D from D+ on 2/12/2020 due to a noticeable decline in the total return index, growth index and volatility index.
D
Sell
9/6/2019Upgraded
CVR Medical Corp. (CVM.V) was upgraded to D+ from D on 9/6/2019 due to a significant increase in the efficiency index, growth index and valuation index. Operating cash flow increased 38.51% from -$1.25M to -$766.6, earnings per share increased from -$0.0213 to -$0.0163, and EBIT increased 19.2% from -$2.02M to -$1.63M.
CVR Medical Corp. (CVM.V) was upgraded to D+ from D on 9/6/2019 due to a significant increase in the efficiency index, growth index and valuation index. Operating cash flow increased 38.51% from -$1.25M to -$766.6, earnings per share increased from -$0.0213 to -$0.0163, and EBIT increased 19.2% from -$2.02M to -$1.63M.
D
Sell
4/30/2018Upgraded
CVR Medical Corp. (CVM.V) was upgraded to D from D- on 4/30/2018 due to a large increase in the solvency index, efficiency index and volatility index.
CVR Medical Corp. (CVM.V) was upgraded to D from D- on 4/30/2018 due to a large increase in the solvency index, efficiency index and volatility index.
D
Sell
4/28/2017Downgrade
CVR Medical Corp. (CVM.V) was downgraded to D- from D on 4/28/2017 due to a significant decline in the efficiency index, total return index and valuation index. Net income declined 95.9% from -$749.5 to -$1.47M, and total capital declined 60.28% from $2.52M to $999.9.
CVR Medical Corp. (CVM.V) was downgraded to D- from D on 4/28/2017 due to a significant decline in the efficiency index, total return index and valuation index. Net income declined 95.9% from -$749.5 to -$1.47M, and total capital declined 60.28% from $2.52M to $999.9.
D
Sell
12/9/2016Downgrade
CVR Medical Corp. (CVM.V) was downgraded to D from D+ on 12/9/2016 due to a decline in the valuation index.
CVR Medical Corp. (CVM.V) was downgraded to D from D+ on 12/9/2016 due to a decline in the valuation index.
D
Sell
12/1/2016Downgrade
CVR Medical Corp. (CVM.V) was downgraded to D+ from C- on 12/1/2016 due to a significant decline in the efficiency index, growth index and volatility index. Operating cash flow declined 146,555.56% from -$900 to -$1.32M, EBIT declined 3,076.62% from -$30.8 to -$978.4, and net income declined 2,842.75% from -$25.5 to -$750.4.
CVR Medical Corp. (CVM.V) was downgraded to D+ from C- on 12/1/2016 due to a significant decline in the efficiency index, growth index and volatility index. Operating cash flow declined 146,555.56% from -$900 to -$1.32M, EBIT declined 3,076.62% from -$30.8 to -$978.4, and net income declined 2,842.75% from -$25.5 to -$750.4.
C
Hold
9/30/2016Upgraded
CVR Medical Corp. (CVM.V) was upgraded to C- from D+ on 9/30/2016 due to a large increase in the total return index, efficiency index and growth index. Operating cash flow increased 85.71% from -$6.3 to -$900, earnings per share increased from -$0.0012 to -$0.0011, and net income increased 5.56% from -$27 to -$25.5.
CVR Medical Corp. (CVM.V) was upgraded to C- from D+ on 9/30/2016 due to a large increase in the total return index, efficiency index and growth index. Operating cash flow increased 85.71% from -$6.3 to -$900, earnings per share increased from -$0.0012 to -$0.0011, and net income increased 5.56% from -$27 to -$25.5.
D
Sell
1/4/2016Downgrade
Big Bar Resources Corporation (BBRH.V) was downgraded to D+ from C- on 1/4/2016 due to a decline in the volatility index.
Big Bar Resources Corporation (BBRH.V) was downgraded to D+ from C- on 1/4/2016 due to a decline in the volatility index.
C
Hold
12/1/2015Downgrade
Big Bar Resources Corporation (BBRH.V) was downgraded to C- from C on 12/1/2015 due to a decline in the growth index and valuation index. Operating cash flow declined 85.71% from -$2.1 to -$300.
Big Bar Resources Corporation (BBRH.V) was downgraded to C- from C on 12/1/2015 due to a decline in the growth index and valuation index. Operating cash flow declined 85.71% from -$2.1 to -$300.
C
Hold
4/6/2015Upgraded
Big Bar Resources Corporation (BBRH.V) was upgraded to C from C- on 4/6/2015 due to a noticeable increase in the growth index and solvency index. EBIT increased 5.75% from -$31.3 to -$33.1.
Big Bar Resources Corporation (BBRH.V) was upgraded to C from C- on 4/6/2015 due to a noticeable increase in the growth index and solvency index. EBIT increased 5.75% from -$31.3 to -$33.1.
C
Hold
11/28/2014Downgrade
Big Bar Resources Corporation (BBRH.V) was downgraded to C- from C on 11/28/2014 due to a significant decline in the volatility index, solvency index and growth index.
Big Bar Resources Corporation (BBRH.V) was downgraded to C- from C on 11/28/2014 due to a significant decline in the volatility index, solvency index and growth index.
C
Hold
4/23/2014Upgraded
Big Bar Resources Corporation (BBRH.V) was upgraded to C from C- on 4/23/2014 due to a significant increase in the volatility index, efficiency index and total return index. Net income increased 139.89% from -$36.1 to -$86.6, and total capital increased 109.34% from -$76 to -$159.1.
Big Bar Resources Corporation (BBRH.V) was upgraded to C from C- on 4/23/2014 due to a significant increase in the volatility index, efficiency index and total return index. Net income increased 139.89% from -$36.1 to -$86.6, and total capital increased 109.34% from -$76 to -$159.1.
